Giulia Mantero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Giulia Mantero has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Fabio Benfenati
Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genoa, Italy
3 shared publications - Anna Rocchi
Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy
2 shared publications - Dmytro Shmal
Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Largo Rosanna Benzi, 10, 16132, Genova, Italy
2 shared publications - Elisabetta Colombo
Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genova, Italy
2 shared publications - Grazia Pertile
Department of Ophthalmology, IRCCS Sacrocuore Don Calabria Hospital, Negrar, Verona, Italy
2 shared publications - Guglielmo Lanzani
Center for Nano Science and Technology, Istituto Italiano di Tecnologia 2 , Milan
2 shared publications
Latest Publications
- Open Access
- 30 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 8721
Graphene oxide increases the phototransduction efficiency of copolymeric nanoimplants and rescues visual functions in rat and pig models of Retinitis pigmentosa
Photoreceptor degeneration in Retinitis pigmentosa (RP) is a leading cause of inherited blindness, for which few effective treatments are available. Graphene's exceptional electrical, optical, and mechanical properties, along with its biocompatibility, make it a promising material for retinal stimulation. Building on prior success with conjugated polymers in rodent RP models, we developed injectable retinal nanoimplants that blend a donor-acceptor polymeric architecture with graphene oxide flakes. Here we show that graphene significantly improved the photovoltaic efficiency and enhanced light-evoked responses in blind retinal explants. In RP-affected Royal College of Surgeons rats, a single subretinal injection of these nanoimplants restored light-driven behaviors and visual brain activity at lower luminances than polymer-only particles without any proinflammatory effects. Moreover, this technology restored retinal activity in a pig model of chemically induced degeneration, demonstrating the valuable translational potential of the injectable nanoplatform in the treatment of retinal degenerative diseases.
- 30 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 8721
Open AccessGraphene oxide increases the phototransduction efficiency of copolymeric nanoimplants and rescues visual functions in rat and pig models of Retinitis pigmentosa
Photoreceptor degeneration in Retinitis pigmentosa (RP) is a leading cause of inherited blindness, for which few effective treatments are available. Graphene's exceptional electrical, optical, and mechanical properties, along with its biocompatibility, make it a promising material for retinal stimulation. Building on prior success with conjugated polymers in rodent RP models, we developed injectable retinal nanoimplants that blend a donor-acceptor polymeric architecture with graphene oxide flakes. Here we show that graphene significantly improved the photovoltaic efficiency and enhanced light-evoked responses in blind retinal explants. In RP-affected Royal College of Surgeons rats, a single subretinal injection of these nanoimplants restored light-driven behaviors and visual brain activity at lower luminances than polymer-only particles without any proinflammatory effects. Moreover, this technology restored retinal activity in a pig model of chemically induced degeneration, demonstrating the valuable translational potential of the injectable nanoplatform in the treatment of retinal degenerative diseases.
- Open Access
- 27 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-19
Light-induced charge generation in polymeric nanoparticles restores vision in advanced-stage retinitis pigmentosa rats
Retinal dystrophies such as Retinitis pigmentosa are among the most prevalent causes of inherited legal blindness, for which treatments are in demand. Retinal prostheses have been developed to stimulate the inner retinal network that, initially spared by degeneration, deteriorates in the late stages of the disease. We recently reported that conjugated polymer nanoparticles persistently rescue visual activities after a single subretinal injection in the Royal College of Surgeons rat model of Retinitis pigmentosa. Here we demonstrate that conjugated polymer nanoparticles can reinstate physiological signals at the cortical level and visually driven activities when microinjected in 10-months-old Royal College of Surgeons rats bearing fully light-insensitive retinas. The extent of visual restoration positively correlates with the nanoparticle density and hybrid contacts with second-order retinal neurons. The results establish the functional role of organic photovoltaic nanoparticles in restoring visual activities in fully degenerate retinas with intense inner retina rewiring, a stage of the disease in which patients are subjected to prosthetic interventions.
- 27 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-19
Open AccessLight-induced charge generation in polymeric nanoparticles restores vision in advanced-stage retinitis pigmentosa rats
Retinal dystrophies such as Retinitis pigmentosa are among the most prevalent causes of inherited legal blindness, for which treatments are in demand. Retinal prostheses have been developed to stimulate the inner retinal network that, initially spared by degeneration, deteriorates in the late stages of the disease. We recently reported that conjugated polymer nanoparticles persistently rescue visual activities after a single subretinal injection in the Royal College of Surgeons rat model of Retinitis pigmentosa. Here we demonstrate that conjugated polymer nanoparticles can reinstate physiological signals at the cortical level and visually driven activities when microinjected in 10-months-old Royal College of Surgeons rats bearing fully light-insensitive retinas. The extent of visual restoration positively correlates with the nanoparticle density and hybrid contacts with second-order retinal neurons. The results establish the functional role of organic photovoltaic nanoparticles in restoring visual activities in fully degenerate retinas with intense inner retina rewiring, a stage of the disease in which patients are subjected to prosthetic interventions.
- Top Cited PapersOpen Access
- 29 June 2020
- Published by Springer Nature in Nature Nanotechnology
- Vol. 15 (8) , 698-708
Subretinally injected semiconducting polymer nanoparticles rescue vision in a rat model of retinal dystrophy
Inherited retinal dystrophies and late-stage age-related macular degeneration, for which treatments remain limited, are among the most prevalent causes of legal blindness. Retinal prostheses have been developed to stimulate the inner retinal network; however, lack of sensitivity and resolution, and the need for wiring or external cameras, have limited their application. Here we show that conjugated polymer nanoparticles (P3HT NPs) mediate light-evoked stimulation of retinal neurons and persistently rescue visual functions when subretinally injected in a rat model of retinitis pigmentosa. P3HT NPs spread out over the entire subretinal space and promote light-dependent activation of spared inner retinal neurons, recovering subcortical, cortical and behavioural visual responses in the absence of trophic effects or retinal inflammation. By conferring sustained light sensitivity to degenerate retinas after a single injection, and with the potential for high spatial resolution, P3HT NPs provide a new avenue in retinal prosthetics with potential applications not only in retinitis pigmentosa, but also in age-related macular degeneration.
- 29 June 2020
- Published by Springer Nature in Nature Nanotechnology
- Vol. 15 (8) , 698-708
Top Cited PapersOpen AccessSubretinally injected semiconducting polymer nanoparticles rescue vision in a rat model of retinal dystrophy
Inherited retinal dystrophies and late-stage age-related macular degeneration, for which treatments remain limited, are among the most prevalent causes of legal blindness. Retinal prostheses have been developed to stimulate the inner retinal network; however, lack of sensitivity and resolution, and the need for wiring or external cameras, have limited their application. Here we show that conjugated polymer nanoparticles (P3HT NPs) mediate light-evoked stimulation of retinal neurons and persistently rescue visual functions when subretinally injected in a rat model of retinitis pigmentosa. P3HT NPs spread out over the entire subretinal space and promote light-dependent activation of spared inner retinal neurons, recovering subcortical, cortical and behavioural visual responses in the absence of trophic effects or retinal inflammation. By conferring sustained light sensitivity to degenerate retinas after a single injection, and with the potential for high spatial resolution, P3HT NPs provide a new avenue in retinal prosthetics with potential applications not only in retinitis pigmentosa, but also in age-related macular degeneration.